FDA, CDC support resuming use of J&J vaccine after advisory panel vote

While health officials have documented more cases of a rare blood clotting syndrome associated with J&J's vaccine, a CDC committee supported use of the shot with an added warning.

Original source: https://www.healthcaredive.com/news/cdc-acip-johnson-johnson-vaccine-meeting/599012/